Latest News

Cobalt Light Systems Limited (“Cobalt”) and The University of Hull are pleased to announce the approval of a grant under the Knowledge Transfer Partnership programme (KTP). The grant aims to help develop and apply advanced “chemometric” data analysis techniques, which will improve the quality of information determined using Cobalt’s products.

Cobalt Light Systems has confirmed its autumn schedule of conferences and exhibitions. Starting with UK PharmSci in Nottingham on the 1st of September and running through to JPAG on December 2nd, Cobalt will be present at five pharmaceutically-oriented shows. The biggest shows will be FACSS in Raleigh, NC (17th October) and EAS in Somerset, NJ (15th November), both in the USA. This season also marks the first attendance o

Cobalt Light Systems will give an oral presentation at the SPIE Security and Defence Conference on Monday 20 September 2010.  The company’s CEO, Dr. Paul Loeffen, will speak in the afternoon in session 2: Local Sensing: Nuclear, Crime Scenes, Narcotics, Explosives, and Chemical and Biological Agents II, which starts at 13:20.

Expo Technologies, leaders in Pharma PAT development and implementation, announce a key strategic partnership with high speed analysis company Cobalt Light Systems today.

 Professor Pavel Matousek, Chief Scientific Officer of Cobalt Light Systems Limited and Science and Technology Facilities Council (STFC) Fellow, has been appointed as a Fellow of the Royal Society of Chemistry (FRSC).

Cobalt Light Systems Limited (Cobalt) announces that a key patent application underpinning its proprietary Spatially Offset Raman Spectroscopy (SORS) technology has been granted in the USA;

Matousek, P. and Parker A.W., “Apparatus for Depth-Selective Raman Spectroscopy”, US 7,652,763.

Cobalt Light Systems has appointed Paul Loeffen as the new chief executive officer (CEO). Paul has direct experience of managing early-stage companies in this sector having co-founded Oxford Diffraction Limited in 2001 where he was the CEO until its acquisition in 2008 (in a deal worth $48million in total). Paul has held management positions in Oxford Instruments plc and Varian, Inc. in marketing and general management.

Cobalt’s Chief Scientific Officer, Prof. Pavel Matousek is to be presented with the prestigious Charles Mann Award by the Federation of Analytical Chemistry and Spectroscopy Societies (FACSS) at its annual conference in Louisville, KY in October 2009. The award is given to individuals who've demonstrated advancement in the field of applied Raman Spectroscopy.

Mike Hargreaves, Cobalt’s Applications Scientist, has been invited to talk at a major security conference. The SPIE’s European Security and Defence conference is in Berlin from August 31st to the 3rd of September. It is an event “that bridges the divide between fundamental optical science and the application of the underpinning technologies in advanced security and defence systems”.

Cobalt is giving pharmaceutical companies the first opportunity to see its TRS100 instrument at Pharmaceutical Co-Crystals 2009 and Amorphous Pharmaceutical Materials 2009 in Amsterdam on September 21-22. . The TRS100 is a purpose-built rapid analysis machine for pharmaceutical assay.